Watch RMTI. Know when insiders buy.
One email the day a filing lands. Free.
RMTI
ROCKWELL MEDICAL, INC.
8.37
−0.20 −2.33%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
37
FLAG · shorts 37
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $33.7MP/E —DIV YIELD —FCF YIELD 4.56%REV TTM —NET INCOME −$5.1MNET CASH $1.5M52W 5.19 – 12.70SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$1.1M | −$1.2M | — | -0.34 | $2.1M | $617K | $1.5M | Aug 13 |
| Q1 2026 · Mar 31 | — | — | — | −$1.5M | −$1.6M | — | -0.04 | −$167K | $425K | −$592K | Aug 13 |
| Q4 2025 · Dec 31derived | — | — | — | −$398K | −$554K | — | -0.01 | $2.3M | $86K | $2.2M | Mar 26 |
| Q3 2025 · Sep 30 | — | — | — | −$1.6M | −$1.8M | −205.3% | -0.05 | −$1.3M | $229K | −$1.5M | Nov 12 |
| Q2 2025 · Jun 30 | — | — | — | −$1.3M | −$1.5M | −535.0% | -0.05 | $1.8M | $164K | $1.7M | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$1.4M | −$1.5M | — | -0.04 | −$3.5M | $63K | −$3.5M | Aug 13 |
| Q4 2024 · Dec 31derived | — | — | — | −$519K | −$756K | — | -0.04 | $865K | $395K | $470K | Mar 26 |
| Q3 2024 · Sep 30 | — | — | — | $1.9M | $1.7M | — | 0.04 | $4.3M | $191K | $4.1M | Nov 12 |
| Q2 2024 · Jun 30 | — | — | — | $515K | $343K | — | 0.01 | $1.4M | $286K | $1.2M | Nov 12 |
| Q1 2024 · Mar 31 | — | — | — | −$1.3M | −$1.7M | — | -0.06 | −$2.4M | $139K | −$2.5M | Nov 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$547K | −$1.5M | — | -0.05 | −$43K | $43K | −$86K | Mar 20 |
| Q3 2023 · Sep 30 | — | — | — | −$1.7M | −$1.9M | — | -0.07 | −$3.8M | — | — | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$4.7M | −$5.3M | — | -0.15 | −$659K | $542K | −$1.2M | — | — |
| FY2024 · to Dec 31 | — | — | $608K | −$480K | — | -0.03 | $4.2M | $1M | $3.2M | — | — |
| FY2023 · to Dec 31 | — | — | −$6.7M | −$8.4M | — | -0.37 | −$9.4M | $284K | −$9.7M | — | — |
| FY2022 · to Dec 31 | — | — | −$16.8M | −$18.7M | — | -1.31 | −$16.9M | — | — | — | — |
| FY2021 · to Dec 31 | — | — | −$30.3M | −$32.7M | — | -3.83 | −$33.5M | — | — | — | — |
| FY2020 · to Dec 31 | — | — | −$28.4M | −$30.9M | — | -0.41 | −$29.6M | — | — | — | — |
Every number comes from ROCKWELL MEDICAL, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.